Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways

Thorax

Volumn 59, Issue 4, 2004, Pages 313-317

  Prause, O ^a   Bozinovski, S ^b   Anderson, G P ^b   Linden A ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Lung Disease Research Laboratories   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; INTERLEUKIN 17; PROTEIN PRECURSOR;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SUBSTRATE; LUNG LAVAGE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; RESPIRATORY TRACT INFLAMMATION; T LYMPHOCYTE;

ANIMALS; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; ENDOPEPTIDASES; INTERLEUKIN-17; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; NEUTROPHILS;

EID: 1942501856     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2003.008854     Document Type: Article

References (37)

1. Birkedal-Hansen H, Moore WG, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
2. Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 2003;28:12-24.
3. Cuzner ML, Opdenakker G. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J Neuroimmunol 1999;94:1-14.
4. Lee YC, Lee HB, Rhee YK, et al. The involvement of matrix metalloproteinase-9 in airway inflammation of patients with acute asthma. Clin Exp Allergy 2001;31:1623-30.
5. Suga M, Iyonaga K, Okamoto T, et al. Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2000;162:1949-56.
6. Torii K, Iida K, Miyazaki Y, et al. Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am J Respir Crit Care Med 1997;155:43-6.
7. Keatings VM, Barnes PJ. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med 1997;155:449-53.
8. Betsuyaku T, Nishimura M, Takeyabu K, et al. Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med 1999;159:1985-91.
9. Ohnishi K, Takagi M, Kurokawa Y, et al. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest 1998;78:1077-87.
10. Shapiro SD, Senior RM. Matrix metalloproteinases. Matrix degradation and more. Am J Respir Cell Mol Biol 1999;20:1100-2.
11. Zaoui P, Barro C, Morel F. Differential expression and secretion of gelatinases and tissue inhibitor of metalloproteinase-1 during neutrophil adhesion. Biochim Biophys Acta 1996;1290:101-12.
12. Campbell EJ, Senior RM, Welgus HG. Extracellular matrix injury during lung inflammation. Chest 1987;92:161-7.
13. Yao PM, Lemjabbar H, D'Ortho MP, et al. Balance between MMP-9 and TIMP-1 expressed by human bronchial epithelial cells: relevance to asthma. Ann NY Acad Sci 1999;878:512-4.
14. Schnaper HW, Grant DS, Stetler-Stevenson WG, et al. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol 1993;156:235-46.
15. Welgus HG, Campbell EJ, Cury JD, et al. Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J Clin Invest 1990;86:1496-502.
16. Saetta M, Turato G, Facchini FM, et al. Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. Am J Respir Crit Care Med 1997;156:1633-9.
17. Fahy JV, Kim KW, Liu J, et al. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995;95:843-52.
18. Meyer KC, Zimmerman J. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis. J Lab Clin Med 1993;121:654-61.
19. Blackwell TS, Christman JW. Defining the lung's response to endotoxin. Am J Respir Crit Care Med 2001;163:1516-7.
20. Lindén A, Adachi M. Neutrophilic airway inflammation and IL-17. Allergy 2002;57:769-75.
21. Laan M, Cui ZH, Hoshino H, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999;162:2347-52.
22. Hoshino H, Laan M, Sjöstrand M, et al. Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo. J Allergy Clin Immunol 2000;105:143-9.
23. Molet S, Hamid Q, Davoine F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001;108:430-8.
24. Lindén A. Role of interleukin-17 and the neutrophil in asthma. Int Arch Allergy Immunol 2001;126:179-84.
25. Laan M, Palmberg L, Larsson K, et al. Free, soluble interleukin-17 protein during severe inflammation in human airways. Eur Respir J 2002;19:534-7.
26. Miyamoto M, Prause O, Sjöstrand M, et al. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol 2003;170:5335-42.
27. Kolls JK, Kanaly ST, Ramsay AJ. Interleukin-17: an emerging role in lung inflammation. Am J Respir Cell Mol Biol 2003;28:9-11.
28. Bozinovski S, Jones JE, Vlahos R, et al. Granulocyte/macrophage-colony- stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NFkappa B and AP-1 in vivo. J Biol Chem 2002;277:42808-14.
29. Aoki K, Ishida Y, Kikuta N, et al. Role of CXC chemokines in the enhancement of LPS-induced neutrophil accumulation in the lung of mice by dexamethasone. Biochem Biophys Res Commun 2002;294:1101-8.
30. Ferretti S, Bonneau O, Dubois GR, et al. IL-17, Produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 2003;170:2106-12.
31. Jovanovic DV, Martel-Pelletier J, Di Battista JA, et al. Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. Arthritis Rheum 2000;43:1134-44.
32. Allport JR, Ding H, Collins T, et al. Endothelial-dependent mechanisms regulate leukocyte transmigration: a process involving the proteasome and disruption of the vascular endothelial-cadherin complex at endothelial cell-to-cell junctions. J Exp Med 1997;186:517-27.
33. Del Maschio A, Zanetti A, Corada M, et al. Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherent junctions. J Cell Biol 1996;135:497-510.
34. Delclaux C, Delacourt C, D'Ortho MP, et al. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 1996;14:288-95.
35. Betsuyaku T, Shipley JM, Liu Z, et al. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. Am J Respir. Cell Mol Biol 1999;20:1303-9.
36. Ye P, Garvey PB, Zhang P, et al. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol 2001;25:335-40.
37. Bottcher T, Spreer A, Azeh I, et al. Matrix metalloproteinase-9 deficiency impairs host defense mechanisms against Streptococcus pneumoniae in a mouse model of bacterial meningitis. Neurosci Lett 2003;338:201-4.